Microbot Medical MBOT Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.
The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's increase (decrease) in other accounts payable and accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's increase (decrease) in other accounts payable and accrued liabilities?
- Microbot Medical (MBOT) reported increase (decrease) in other accounts payable and accrued liabilities of $384K in Q1 2026.
- How has Microbot Medical's increase (decrease) in other accounts payable and accrued liabilities changed year-over-year?
- Microbot Medical's increase (decrease) in other accounts payable and accrued liabilities increased by 162.2% year-over-year, from -$617K to $384K.